Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.

Conditions:   Scar;   Cicatrix;   Hypertrophic Scar;   Skin Graft Scar;   Skin Graft Complications;   Donor Site Complication;   Keloid Interventions:   Drug: Fibrosis-Inhibiting-Compound-FS2;   Other: Vehicle moisture balancing base Sponsor:   University of British Columbia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Keloids | Research | Study